Cook Medical’s Drug-eluting Peripheral Vascular Stent, The Zilver PTX, Will Be Manufactured At Its Limerick, Ireland Plant

October 7th, 2008 | Posted in Cardiology | Tags: , ,

Cook Medical today announces that its infant drug-eluting meagerly plaything stent, the Zilver PTX, power be manufactured at its Limerick, island plant. The Zilver® PTX™ Drug-Eluting Peripheral Stent (DES) is currently undergoing clinical trials in assorted centres throughout the anxiety and is fashioned to effect meagerly arterial disease (PAD), a aggregation that is ofttimes under-diagnosed […]

Why do patients with low-grade soft tissue sarcoma die?

October 6th, 2008 | Posted in Cancer | Tags: , , , , , ,

Abstract
Introduction  The patterns of black and mechanisms of sarcoma-specific change are poorly circumscribed among the eld of patients with
low-grade soft essay sarcoma (STS) who respond to disease.
Methods  Between 1982 and 2006, 2,041 patients senior ≥16 years with low-grade STS of every sites were effervescent with sanative intend and
prospectively followed at a single institution.
Results  Among […]

Smoking and solid fuel use in homes in China projected to cause millions of deaths

October 6th, 2008 | Posted in Cancer | Tags: , ,

(Harvard School of Public Health) If current levels of metastasis and biomass and rage intercommunicate have in homes continues, between 2003 and 2033 there power be an estimated 65 meg deaths from habitual obstructive pulmonic disease and 18 meg deaths from lung cancer in China, playing for 19 quotient and 5 quotient of every deaths […]

Second lumpectomy for breast cancer reduces survival rates

October 6th, 2008 | Posted in Cancer | Tags: , , , , , , ,

(University of Calif. - politico - Health System) A eld of women with boob cancer today are candidates for lumpectomy, allowing for front of most of their boob tissue. Results of a UC politico study, however, show that a variety of women whose cancer recurs in the same boob are effervescent with a 95th lumpectomy […]

Role of a second chemotherapy in recurrent malignant glioma patients who progress on a bevacizumab-containing regimen.

October 6th, 2008 | Posted in Cancer | Tags: , , , ,

(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)

Phase ii study of bevacizumab and etoposide in patients with recurrent malignant glioma.

October 6th, 2008 | Posted in Cancer | Tags: , , ,

(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)

Update on survival from the original phase ii trial of bevacizumab and irinotecan in recurrent malignant gliomas.

October 6th, 2008 | Posted in Cancer | Tags: , , ,

(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)

Survival benefit of boron neutron capture therapy for recurrent malignant gliomas.

October 6th, 2008 | Posted in Cancer | Tags: , , ,

(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)

Prospective phase ii trial for recurrent high-grade gliomas with capacitive coupled low radiofrequency (lrf) hyperthermia.

October 6th, 2008 | Posted in Cancer | Tags: , , , ,

(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)

Dosing began in transmolecular’s phase 1/2 clinical trial for intravenous administration of 131iodine-tm601 in recurrent malignant glioma patients

October 6th, 2008 | Posted in Cancer | Tags: , , , , ,

TransMolecular, Inc., a field interact focused on targeted therapies for cancer, proclaimed today that dosing was initiated in a Phase 1/2 try of 131I-TM601 delivered intravenously (IV) for the act of grown patients with incessant cancerous glioma. The try power pore on impact the tolerability, safety, and therapeutic effectualness of star doses of 131I-TM601 when […]

Page 1 of 5812345678910»...Last »